Projected to grow from US$2.75 billion in 2024 to US$6.63 billion by 2033 at 10.4% CAGR, the RNAi technology market thrives on end-user segments like pharma companies. Dive into segmentation by type, clinical successes like Oxlumo, and challenges in IP amid competitive CRISPR landscapes. https://finance.yahoo.com/news/rnai-technology-market-size-reach-150000762.html